IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells

Area of Science:

• Immunology
• Cancer Biology
• T-cell Biology

Background:

• CD4(+) T cells are crucial for antitumor immunity.
• Polyfunctional CD4(+) T cells producing multiple cytokines are desirable for cancer immunotherapy.
• Mechanisms for inducing polyfunctional CD4(+) T cells and their therapeutic potential are unclear.

Purpose of the Study:

• To investigate the mechanisms of inducing polyfunctional CD4(+) T cells.
• To determine if IL-7 can induce polyfunctional CD4(+) T cells.
• To evaluate the therapeutic efficacy of IL-7-induced polyfunctional CD4(+) T cells in cancer treatment.

Main Methods:

• Exposing CD4(+) T cells to IL-7 during antigenic stimulation.
• Analyzing cytokine production (IFNγ, IL-2, TNFα) and granzyme B expression.
• Investigating STAT5 signaling pathway activation.
• Assessing in vivo tumor trafficking, expansion, and eradication after adoptive transfer.

Main Results:

• IL-7 induced polyfunctional CD4(+) T cells expressing IFNγ, IL-2, TNFα, and granzyme B.
• IL-7 mediated polyfunctionality through increased histone acetylation and STAT5 activation.
• In vitro generated polyfunctional CD4(+) T cells trafficked to tumors and expanded intratumorally.
• Adoptive transfer of these cells eradicated established tumors, promoting antigen spreading and CD8(+) T cell activation.

Conclusions:

• IL-7 signaling is a novel mechanism to induce polyfunctional CD4(+) T cells with stemness potential.
• IL-7-driven polyfunctional CD4(+) T cells represent a promising strategy for adoptive T-cell immunotherapy.
• This study reveals a new therapeutic application for IL-7 in cancer treatment.